@Dyne_tx Dyne Therapeutics

Dyne Therapeutics posts on X about $dyn, people with, dmd, platform the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.

Engagements: [--] #

• [--] Week [---] -93%
• [--] Month [-----] +303%
• [--] Months [------] -14%
• [--] Year [------] -9.50%

Mentions: [--] #

• [--] Month [--] -74%
• [--] Months [--] -38%
• [--] Year [---] -43%

Followers: [-----] #

• [--] Week [-----] +0.16%
• [--] Month [-----] +0.39%
• [--] Months [-----] +5.10%
• [--] Year [-----] +13%

CreatorRank: undefined #

Social Influence

Social category influence stocks 87% finance 5% countries 2% financial services 1% currencies 1%

Social topic influence $dyn #1, people with 6%, dmd 5%, platform 3%, in the 3%, dedication 2%, hosted 2%, make a 2%, morgan stanley 2%, investment 2%

Top accounts mentioned or mentioned by @myotonicstrong @fshdsociety @mdaorg @cureduchenne @usfda @parentprojectmd @morganstanley @jpmorgan @jmaraganore @treatnmd @muscleandnerve @chihealthtech @stifelinst @jasonpaulrhodes @atlasventure @aanmember @jettfoundation @dppspain @pegsboston @ispororg

Top assets mentioned Dyne Therapeutics, Inc. (DYN) Morgan Stanley (MS)

Top Social Posts

Top posts by engagements in the last [--] hours

"We announced positive topline results from our Phase 1/2 DELIVER trial of z-rostudirsen in DMD: REC met its primary endpoint & maintained a favorable safety profile. Read more: https://bit.ly/3Yku2Sx https://bit.ly/3Yku2Sx"
X Link 2025-12-08T11:39Z [----] followers, [---] engagements

"At the @jpmorgan Healthcare Conference well share how our clinically validated FORCE platform is advancing therapies designed to deliver functional improvement for genetically driven neuromuscular diseases. Learn more: $DYN #JPM26 #JPM2026 https://bit.ly/3zHnp4e https://bit.ly/3zHnp4e"
X Link 2026-01-07T14:15Z [----] followers, [---] engagements

"Once you open that drug delivery door you go all in." Great insights from @JMaraganore for our first FORCEs in Biotech session of the new year. Key takeaways: Solving delivery is the game-changer➡Anticipate the unpredictables➡Scale expertise while keeping your startup soul"
X Link 2026-02-03T14:42Z [----] followers, [----] engagements

"Were pleased to welcome Vikram Karnani to Dynes Board of Directors. Vikrams deep rare disease experience and proven track record in product launches and value creation will be critical as Dyne approaches commercialization. Read more: https://bit.ly/48Ube2M https://bit.ly/48Ube2M"
X Link 2025-12-23T12:38Z [----] followers, [---] engagements

"Japans Ministry of Health Labour and Welfare has granted Orphan Drug designation to z-basivarsen for DM1. Learn more: $DYN https://bit.ly/3NzEuUb https://bit.ly/3NzEuUb"
X Link 2026-01-20T12:32Z [----] followers, [---] engagements

"Wrapping up an inspiring few days at the @Treat_NMD conference. Thank you to the researchers clinicians and advocates who came together to share insights advance collaboration and keep the focus on the neuromuscular disease community"
X Link 2026-02-13T16:01Z [----] followers, [---] engagements

"In honor of #RareDiseaseDay we recognize individuals and families living with rare diseases. Your strength resilience and advocacy inspire us to push forward in developing meaningful treatments. We appreciate you today and every day"
X Link 2025-02-28T16:54Z [----] followers, [---] engagements

"New research in @MuscleAndNerve explores the high clinical and economic burden of myotonic dystrophy (DM) and the need for improved cost-effective care. Read more: https://bit.ly/4bp8FFo https://bit.ly/4bp8FFo"
X Link 2025-03-04T16:10Z [----] followers, [---] engagements

"A huge shoutout to our incredible Dynamos Your passion creativity and dedication fuel our mission to develop therapies for serious neuromuscular diseases. Thank you for your hard work and commitmentyou make everything we do possible #EmployeeAppreciationDay"
X Link 2025-03-07T15:29Z [----] followers, [---] engagements

"Join us at #OTPBoston hosted by @CHI_Healthtech for our presentation on the FORCE Platform and its role in delivering targeted therapies to muscle unlocking potential treatments for FSHD. Explore the agenda and learn more: https://bit.ly/4hktvXR https://bit.ly/4hktvXR"
X Link 2025-03-10T17:17Z [----] followers, [---] engagements

"On March [--] we will participate in a fireside chat at the @StifelInst CNS Forum at 4:00 p.m. Register to listen the webcast: $DYN #biotechnology https://bit.ly/3XJaN5e https://bit.ly/3XJaN5e"
X Link 2025-03-12T14:47Z [----] followers, [---] engagements

"Leaving #MDA2025 inspired by the progress in neuromuscular disorder research and care. Grateful to connect with peers clinicians scientists and the communityall working together to make a difference"
X Link 2025-03-19T21:53Z [----] followers, [---] engagements

"Were honored to sponsor the upcoming MDUK Oxford Neuromuscular Centre Annual Meeting Join us and other industry experts for a panel discussion on early therapies for DMD. Check out the agenda: https://bit.ly/4inRerN https://bit.ly/4inRerN"
X Link 2025-03-24T15:05Z [----] followers, [---] engagements

"Were proud to sponsor the Duchenne UK New Horizons conference If youre attending dont miss the industry panel session where well discuss the latest advancements in DMD treatment approaches. Learn more about the conference: https://bit.ly/3TkbH6K https://bit.ly/3TkbH6K"
X Link 2025-03-26T15:13Z [----] followers, [---] engagements

"Introducing FORCEs in Biotecha series of conversations with experts from the #biotech ecosystem. We kicked off with Dynes Chairman @JasonPaulRhodes to discuss the state of biotech and Dynes rapid evolution from compelling idea to clinical-stage company. @atlasventure"
X Link 2025-03-27T15:08Z [----] followers, [---] engagements

"Join us today for a community webinar with @CureDuchenne as we present recently announced data from our DELIVER trial of DYNE-251 in individuals with DMD who are amenable to exon [--] skipping. Register here: https://bit.ly/42hOFAJ https://bit.ly/42hOFAJ"
X Link 2025-04-01T14:03Z [----] followers, [---] engagements

"Next week were headed to the @AANmember annual meeting to present data from the DELIVER & ACHIEVE clinical trials. Register here: https://bit.ly/4ldXMec https://bit.ly/4ldXMec"
X Link 2025-04-03T20:05Z [----] followers, [---] engagements

"Interested in learning about myotonic dystrophy Visit @MyotonicStrong to see a video series designed to help individuals living with DM their families and healthcare providers deepen their understanding about the disease: https://bit.ly/425KitB https://bit.ly/425KitB"
X Link 2025-04-08T17:05Z [----] followers, [---] engagements

"We look forward to joining other experts in #DM1 for the Euro DM CRN meeting. See the agenda and watch our two presentations to learn more about our FORCE platform and its role in delivering targeted therapeutics to muscle: https://bit.ly/4jsLltm https://bit.ly/4jsLltm"
X Link 2025-04-11T17:23Z [----] followers, [---] engagements

"Were proud to sponsor the 18th UK Neuromuscular Translational Research Conference [----]. Join our industry symposium to learn about our ongoing DELIVER & ACHIEVE clinical trials in #DMD and #DM1: https://bit.ly/3RhomW3 https://bit.ly/3RhomW3"
X Link 2025-04-14T16:54Z [----] followers, [---] engagements

"Be sure to join the @JettFoundation for a community webinar on April [--] where well present recently announced data from our DELIVER trial of DYNE-251 in individuals with DMD who are amenable to exon [--] skipping. Register here: https://bit.ly/3ROb3N2 https://bit.ly/3ROb3N2"
X Link 2025-04-14T18:32Z [----] followers, [---] engagements

"A big welcome to Raj as he leads CMC across our pipeline. With [--] yrs in drug dev tech ops & CMC he brings world-class expertise in commercialization & global operations. Excited for whats ahead https://bit.ly/42zt9rb https://bit.ly/42zt9rb"
X Link 2025-04-17T17:37Z [----] followers, [---] engagements

"In honor of Lab Week we celebrate our incredible team the scientists researchers & innovators driving progress for people living with serious neuromuscular diseases. Their dedication fuels our mission every day and were grateful for their curiosity creativity and passion"
X Link 2025-04-20T20:30Z [----] followers, [---] engagements

"Today were celebrating the incredible administrative professionals who keep Dyne running smoothly every day Thank you for all that you do"
X Link 2025-04-23T14:58Z [----] followers, [---] engagements

"#DM1 is a rare progressive muscle disease caused by mutated genetic material. DYNE-101 is designed to address the underlying cause of DM1 with the goal of stopping or reversing disease progression. Watch the video below to learn more. https://www.youtube.com/watchv=gHNBjvgziNA https://www.youtube.com/watchv=gHNBjvgziNA"
X Link 2025-04-28T14:48Z [----] followers, [---] engagements

"As we work urgently to deliver functional improvement to those with neuromuscular diseases were reflecting on moments that inspire our missionlike #RareDiseaseDay where #Dynamos families & advocates shared their stories. #RareDiseaseAwareness"
X Link 2025-04-29T17:20Z [----] followers, [---] engagements

"Were looking forward to connecting with the DM1 community at the @MyotonicStrong Annual Conference and sharing presentations including previously announced data from our ACHIEVE trial in DM1 showing sustained functional improvement. Learn more: https://bit.ly/42OqWbn https://bit.ly/42OqWbn"
X Link 2025-04-30T18:38Z [----] followers, [---] engagements

"If youre at @DPPSpain be sure to catch our presentation highlighting how were leveraging our FORCE platform to deliver potentially transformative therapies that provide functional improvement for patients with DMD. See the agenda: https://bit.ly/3EHBBNc https://bit.ly/3EHBBNc"
X Link 2025-05-01T16:46Z [----] followers, [---] engagements

"Attending @PEGSboston Catch our presentation on how our FORCE Platform enables delivery of novel therapeutics for neuromuscular disorders. See the agenda: https://bit.ly/38oC0nf https://bit.ly/38oC0nf"
X Link 2025-05-12T17:38Z [----] followers, [---] engagements

"Real-world findings from our IMPaCT study of DM1 are being shared at @ISPORorg [----] reinforcing the urgent need for therapies that address the multi-systemic nature of the disease. Check out the agenda: #ISPORAnnual https://bit.ly/44uiCA8 https://bit.ly/44uiCA8"
X Link 2025-05-13T16:45Z [----] followers, [---] engagements

"Join us at @ASGCTherapy [----] where well share presentations on our FORCE platform as well as previously announced data from our ACHIEVE trial in DM1 demonstrating meaningful functional improvement: #ASGCT2025 https://bit.ly/4kcyyLM https://bit.ly/4kcyyLM"
X Link 2025-05-13T18:14Z [----] followers, [---] engagements

"At #TIDESUSA well share a presentation on how our FORCE platform leverages the transferrin receptor to enable delivery of novel therapeutics and demonstrates translatability into the clinic. Learn more: @TIDESInforma https://bit.ly/4dnCesd https://bit.ly/4dnCesd"
X Link 2025-05-19T17:35Z [----] followers, [---] engagements

"Join us for our presentation at the @CureDuchenne Futures conference during the industry update session to learn about our recent DMD data from DYNE-251 in the exon [--] skip amenable population showing functional improvement: #2025FUTURES https://bit.ly/4kx6SBE https://bit.ly/4kx6SBE"
X Link 2025-05-23T14:55Z [----] followers, [---] engagements

"Headed to the AIM National Congress Hear leading experts in neuromuscular disease explore how our FORCE platform is helping to deliver sustained functional improvement to people living with these genetically driven diseases: https://bit.ly/4ky8bAn https://bit.ly/4ky8bAn"
X Link 2025-05-27T14:51Z [----] followers, [---] engagements

"In our latest FORCEs in Biotech conversation Dyne board member Dr. Catherine Stehman-Breen shares insights on building transformative biotech companies and keeping patients at the center of innovation"
X Link 2025-05-28T18:16Z [----] followers, [---] engagements

"On June [--] we will host a webinar with @ParentProjectMD as we present recent data from our DELIVER trial of DYNE-251 in individuals with DMD who are amenable to exon [--] skipping. Register: https://bit.ly/4kkQ5ls https://bit.ly/4kkQ5ls"
X Link 2025-06-02T13:49Z [----] followers, [---] engagements

"Thank you to all of our #Dynamos who joined the @JettFoundations National Challenge with a walk in our local park to raise awareness and funds for the #DMD community You can make a difference too. Donate today and help us fuel hope and progress: https://bit.ly/4jwH8oK https://bit.ly/4jwH8oK"
X Link 2025-06-06T16:10Z [----] followers, [---] engagements

"FSHD Connect hosted by @FSHDSociety and FSHD Europe brings together individuals living with #FSHD their families researchers and advocates. We look forward to engaging with the community and discussing the latest research and progress: https://bit.ly/3FGBXEj https://bit.ly/3FGBXEj"
X Link 2025-06-10T15:08Z [----] followers, [---] engagements

"We were thrilled to recently host Dr. Johanna Hamel at Dyne. She shared how expanding access to research through remote assessments and patient registries helps capture the full story of #MyotonicDystrophy"
X Link 2025-06-13T15:03Z [----] followers, [---] engagements

"Were excited to join the #Duchenne community for the @ParentProjectMDs [----] Annual Conference Register to visit us either virtually or in person at our booth: https://bit.ly/444t0wF https://bit.ly/444t0wF"
X Link 2025-06-17T17:42Z [----] followers, [---] engagements

"Dyne CIO Oxana Beskrovnaya is joining leaders at #BIO2025 to discuss whats driving the RNAissance and how RNA therapeutics are reshaping drug development. Learn more: https://bit.ly/3HL2GQy https://bit.ly/3HL2GQy"
X Link 2025-06-18T13:13Z [----] followers, [---] engagements

"This #WorldFSHDDay we're proud to support the @FSHDSociety and raise awareness of FSHD and its impact including the loss of the ability to smile. Learn more and get involved: https://bit.ly/3xmOSXP https://bit.ly/3xmOSXP"
X Link 2025-06-20T13:18Z [----] followers, [---] engagements

"On Dyne Science Day our #Dynamos shared the research and innovation driving our goal to deliver meaningful functional improvement for people with neuromuscular diseases. Grateful for a team that never stops pushing science forward"
X Link 2025-06-24T13:48Z [----] followers, [---] engagements

"This July join the @MyotonicStrong community for Myotonic Dystrophy in Motion Awareness Month to support wellness for people living with DM. Get involved with weekly activities expert webinars and ways to connect: https://bit.ly/40lcXJZ https://bit.ly/40lcXJZ"
X Link 2025-07-01T14:22Z [----] followers, [---] engagements

"A big congratulations to our #Dynamos who were recently promoted Your hard work dedication and passion for our mission continue to drive Dyne forward as we work to deliver functional improvement for people living with genetically driven neuromuscular diseases"
X Link 2025-07-18T13:29Z [----] followers, [---] engagements

"Celebrating our incredible #Dynamo interns and co-ops this National Intern Day Thank you for your energy dedication and drive as we work to bring functional improvement to people living with genetically driven neuromuscular diseases"
X Link 2025-07-31T13:10Z [----] followers, [---] engagements

"Dr. Kirk Taylor President & CEO of @MALifeSciences joined our FORCEs in Biotech series. His path from music to medicine to biotech is a masterclass in career development. Takeaways: collaboration & trust are non-negotiable as we bring life-changing therapies to patients"
X Link 2025-08-05T13:20Z [----] followers, [---] engagements

"One month to go until #WorldDuchenneAwarenessDay on September [--]. This years theme is Family: The Heart of Care honoring the vital role families play for those living with #Duchenne. Learn more & get involved: #WDAD25 https://bit.ly/3UFKo6u https://bit.ly/3UFKo6u"
X Link 2025-08-07T14:08Z [----] followers, [---] engagements

"Our Dynamos joined the DM community for Myotonic Dystrophy in Motion Awareness Month to show support for individuals and families. Thanks to everyone who participated"
X Link 2025-08-11T15:07Z [----] followers, [---] engagements

"International #MyotonicDystrophy Awareness Day is one month away Help raise awareness of DM and learn how to get involved: #myotonicdystrophyawareness https://bit.ly/3ArcMT4 https://bit.ly/3ArcMT4"
X Link 2025-08-15T13:36Z [----] followers, [---] engagements

"At the Oligonucleotides for CNS Summit were presenting how our FORCE platform delivers therapeutics to muscle and the CNS to bring functional improvement for people with genetically driven neuromuscular diseases. See the agenda: https://bit.ly/3UCE4wM https://bit.ly/3UCE4wM"
X Link 2025-08-28T13:00Z [----] followers, [---] engagements

"Dyne will participate in fireside chats at the @Official_Cantor & @MorganStanley healthcare conferences. To learn about our neuromuscular disease programs & focus on delivering functional improvement for patients register here: https://bit.ly/3zHnp4e https://bit.ly/3zHnp4e"
X Link 2025-09-02T14:26Z [----] followers, [---] engagements

"Were excited to join the @Britishmyology Annual Meeting to present on the potential of DYNE-101 to deliver functional improvement to people with #DM1. Learn more: https://bit.ly/4pemm0I https://bit.ly/4pemm0I"
X Link 2025-09-05T14:25Z [----] followers, [---] engagements

"In honor of #WDAD2025 were sharing the voices of Alan & his mom Catherine. This years theme Family: The Heart of Care highlights the vital role families play in the #DMD journey. Watch their story: https://bit.ly/3Szd3ug https://bit.ly/3Szd3ug"
X Link 2025-09-06T13:00Z [----] followers, [---] engagements

"On #WDAD2025 we stand with the #Duchenne community honoring their strength sharing their stories and learning from their experiences. Learn more & hear their perspectives: #DMD https://bit.ly/3Szd3ug https://bit.ly/3Szd3ug"
X Link 2025-09-07T14:15Z [----] followers, [---] engagements

"Attending the #RNALeaders USA Congress See our presentation on how our FORCE platform targets muscle & CNS to address the root cause of disease. Learn more: https://bit.ly/4npi6d2 https://bit.ly/4npi6d2"
X Link 2025-09-08T18:53Z [----] followers, [---] engagements

"Were thrilled to welcome Monica Fay as our new Chief Medical Affairs Officer who brings deep expertise in rare diseases + a strong track record of successful launches. Looking forward to whats ahead as we work together to deliver for patients https://bit.ly/42zt9rb https://bit.ly/42zt9rb"
X Link 2025-09-17T13:37Z [----] followers, [---] engagements

"We were honored to host Dr. John Day Professor of Neurology Stanford Neuroscience Health Center for a powerful talk on myotonic dystrophy. From its genetic roots to its whole-body impact Dr. Day shared how muscle can be a window to the brain"
X Link 2025-09-18T18:45Z [----] followers, [---] engagements

"DELIVER & ACHIEVE trial data will be shared at the Neuromuscular Study Groups Annual Meeting. Findings show potential to deliver functional improvement in #DMD & #DM1. Event https://bit.ly/46itku5 https://bit.ly/46itku5"
X Link 2025-09-23T15:50Z [----] followers, [---] engagements

"Our #Dynamos joined the @FSHDSociety Walk & Roll to Cure FSHD last weekend to raise awareness and stand with the community. Thanks Dynamos #FSHD"
X Link 2025-09-25T19:38Z [----] followers, [---] engagements

"Being strong isnt only muscles. Strong shows in everyday wins that are different for everyone: brushing hair climbing stairs steadier walks. Honoring #MDAstrong as we advance therapies targeting functional improvement for neuromuscular disease. https://bit.ly/4gKy9zI https://bit.ly/4gKy9zI"
X Link 2025-09-30T14:51Z [----] followers, [---] engagements

"Were pleased to welcome Brian Posner to Dynes Board of Directors. His 30+ years of executive and investment leadership will help guide our mission to deliver functional improvement for people living with neuromuscular diseases. Read more: https://bit.ly/46ztLQT https://bit.ly/46ztLQT"
X Link 2025-10-02T20:08Z [----] followers, [---] engagements

"Data from the ongoing Phase 1/2 ACHIEVE trial in DM1 to be presented at the Congress of the @WorldMuscleSoc continue to demonstrate a favorable safety and efficacy profile for zeleciment basivarsen (formerly known as DYNE-101). See the data: https://bit.ly/4gXSQbu https://bit.ly/4gXSQbu"
X Link 2025-10-06T22:05Z [----] followers, [---] engagements

"Kathleen Tregoning joined us for our FORCEs in Biotech series sharing insights on government affairs: Government affairs isnt bowlingits billiards. Every move every conversation every engagement bounces off another. Its all connected"
X Link 2025-10-15T15:32Z [----] followers, [---] engagements

"Tomorrow Dec. [--] we will host a webcast to share topline results from the registrational cohort of our DELIVER trial of zeleciment rostudirsen (z-rostudirsen) in Duchenne muscular dystrophy (DMD). Join us at 8:00 a.m. ET: https://bit.ly/3KLSnh2 https://bit.ly/3KLSnh2"
X Link 2025-12-07T16:07Z [----] followers, [---] engagements

"Join us Dec. [--] for a webinar with @CureDuchenne. Well share positive topline results from our Phase 1/2 DELIVER trial of z-rostudirsen in DMD. We will review topline dystrophin data and favorable safety and tolerability. Register: https://bit.ly/4s8ysKj https://bit.ly/4s8ysKj"
X Link 2025-12-11T13:50Z [----] followers, [---] engagements

"Join us at the @Pacifichem where well give a presentation on how the FORCE platform was designed to deliver targeted therapeutics to provide functional improvement for people with neuromuscular diseases. Register: https://bit.ly/4s1n16Q https://bit.ly/4s1n16Q"
X Link 2025-12-16T19:50Z [----] followers, [---] engagements

"Today well be presenting at the 22nd Annual @MorganStanley Global Healthcare Conference at 4:05 p.m. ET. Register here: $DYN https://bit.ly/3Zd8sBh https://bit.ly/3Zd8sBh"
X Link 2024-09-05T15:49Z [----] followers, [---] engagements

"We look forward to presenting at upcoming investor conferences this month. Learn more: $DYN https://bit.ly/3zHnp4e https://bit.ly/3zHnp4e"
X Link 2024-11-08T16:55Z [----] followers, [---] engagements

"Today we reported financial results for the third quarter of [----] and provided a corporate update. Read here: $DYN https://bit.ly/4hHbW5T https://bit.ly/4hHbW5T"
X Link 2024-11-12T14:34Z [----] followers, [---] engagements

"Today we announced new clinical data from our ACHIEVE trial showing compelling impact on multiple measures of myotonic dystrophy type [--] (DM1): Learn more and join the live webcast at 8:00 a.m. ET today: https://bit.ly/407SJlT https://bit.ly/407SJlT"
X Link 2025-01-10T11:50Z [----] followers, [---] engagements

"Tomorrow at 10:30 a.m. PT watch our CEO John Cox provide a company overview including our recently announced clinical data from our ACHIEVE trial in DM1. Register here: #JPM2025 https://bit.ly/3E2f7FK https://bit.ly/3E2f7FK"
X Link 2025-01-14T15:52Z [----] followers, [---] engagements

"Were pleased to announce that the @US_FDA has granted Fast Track designation for DYNE-101 for the treatment of myotonic dystrophy type [--] (DM1). Read more: $Dyn https://bit.ly/4jp5GQT https://bit.ly/4jp5GQT"
X Link 2025-01-21T14:15Z [----] followers, [---] engagements

"Our FORCE platform data published in @CommsMedicine shows enhanced oligonucleotide delivery via TfR1 reducing DMPK RNA levels correcting splicing and reversing myotonia in preclinical models of DM1. Read the paper: #biotech #DM1 https://go.nature.com/3PJfOqd https://go.nature.com/3PJfOqd"
X Link 2025-01-21T17:45Z [----] followers, [---] engagements

"On Feb [--] well join @myotonicstrong to share the recently announced clinical data from our ACHIEVE study of DYNE-101. Register here: https://bit.ly/3WO8kpI https://bit.ly/3WO8kpI"
X Link 2025-02-04T21:08Z [----] followers, [---] engagements

"Mark your calendars for #RareDiseaseDay at @ncats_nih_gov on Feb 27-28 This event brings together patients caregivers and researchers to raise awareness about rare diseases and new research. Register here: #RDDatFDANIH https://bit.ly/40W0jAr https://bit.ly/40W0jAr"
X Link 2025-02-13T17:54Z [----] followers, [---] engagements

"Today we announced upcoming presentations at the [----] @MDAorg Clinical & Scientific Conference. Oral presentations include data from the DELIVER trial in DMD and recent positive results from the ACHIEVE trial in DM1. Learn more: https://bit.ly/42Yiic6 https://bit.ly/42Yiic6"
X Link 2025-02-14T21:27Z [----] followers, [---] engagements

"We reported our fourth quarter and full year [----] financial results and business highlights today. Read more: $DYN https://bit.ly/3DawGU4 https://bit.ly/3DawGU4"
X Link 2025-02-27T13:42Z [----] followers, [---] engagements

"We shared Q1 [----] results today highlighting progress on our DM1 and DMD programs that have both demonstrated functional improvement through their ongoing clinical trials. Full update: $DYN https://bit.ly/4m1eu0J https://bit.ly/4m1eu0J"
X Link 2025-05-08T13:11Z [----] followers, [---] engagements

"Tomorrow June [--] we will host a webcast to provide an update on DYNE-101 in DM1 Join us at 8:00 a.m. ET: $DYN https://bit.ly/3FRUEoA https://bit.ly/3FRUEoA"
X Link 2025-06-16T20:15Z [----] followers, [---] engagements

"Today we announced that the @US_FDA has granted Breakthrough Therapy Designation to DYNE-251 for the treatment of patients with DMD amenable to exon [--] skipping. Read here: https://bit.ly/4fly055 https://bit.ly/4fly055"
X Link 2025-08-04T12:40Z [----] followers, [---] engagements

"Sarahs family lives with #DM1 across generations. On #MytonicDystrophy Awareness Day we share her story and journey with DM1. Watch the full video: https://bit.ly/42mTwkM https://bit.ly/42mTwkM"
X Link 2025-09-15T13:56Z [----] followers, [---] engagements

"Today we mark the 5th Annual International #MyotonicDystrophy Awareness Day. At Dyne were honored to be a member of the Global Alliance for Myotonic Dystrophy to help raise awareness and advance research. Learn more: https://bit.ly/3K5zi8U https://bit.ly/3K5zi8U"
X Link 2025-09-15T17:31Z [----] followers, [---] engagements

"November is #NationalFamilyCaregiversMonth a time to recognize the strength and love of those caring for people living with neuromuscular diseases. Hear stories from our community: https://bit.ly/3MmFSWQ https://bit.ly/3MmFSWQ"
X Link 2025-11-04T18:00Z [----] followers, [---] engagements

"We look forward to connecting with the community at the [----] @MDAorg Conference Well be presenting two oral and five poster presentations. Also be sure to visit us at booth #504. Learn more: https://bit.ly/42Yiic6 https://bit.ly/42Yiic6"
X Link 2025-03-14T14:54Z [----] followers, [---] engagements

"Were pleased to share new positive data from our Phase 1/2 DELIVER trial of DYNE-251 in DMD at the @MDAorg Conference. Learn more: $DYN https://bit.ly/3RcHeW9 https://bit.ly/3RcHeW9"
X Link 2025-03-17T11:45Z [----] followers, [---] engagements

"Were excited to announce the appointment of Erick Lucera as CFO of Dyne Therapeutics Erick brings more than thirty years of financial operational & investment experience in the life science industry to Dyne. Welcome to the Dynamo team Erick Read more https://bit.ly/4iCx4dL https://bit.ly/4iCx4dL"
X Link 2025-03-20T20:20Z [----] followers, [---] engagements

"Were excited to share updates to our leadership team as we focus on delivering functional improvement to patients and creating significant shareholder value through our clinical programs pipeline and unique platform. Learn more: #Biotech #Innovation https://bit.ly/4cCNikK https://bit.ly/4cCNikK"
X Link 2025-04-15T12:10Z [----] followers, [---] engagements

"Another step forward in DMD: DYNE-251 our investigational therapeutic for individuals with Duchenne amenable to exon [--] skipping has received orphan drug designation from the @EU_Commission. Learn more: https://bit.ly/4lLRbI7 https://bit.ly/4lLRbI7"
X Link 2025-04-24T13:32Z [----] followers, [---] engagements

"Dyne is presenting new preclinical data on DYNE-302 at this years @FSHDSociety IRC reinforcing the potential of the FORCE platform to achieve functional improvement in FSHD: https://bit.ly/4dM1oRf https://bit.ly/4dM1oRf"
X Link 2025-06-05T13:23Z [----] followers, [---] engagements

"DYNE-101 received Breakthrough Therapy Designation for DM1 from @US_FDA. New long-term data support its promise to deliver meaningful functional improvement as we advance toward potential U.S. Accelerated Approval. Learn more: $DYN https://bit.ly/4laT9Rn https://bit.ly/4laT9Rn"
X Link 2025-06-17T11:18Z [----] followers, [---] engagements

"Today we shared our Q2 [----] results highlighting progress for our #DMD and #DM1 programs. Read here: $DYN https://bit.ly/3U5fi8a https://bit.ly/3U5fi8a"
X Link 2025-07-28T20:20Z [----] followers, [---] engagements

"DYNE-251 has been granted Orphan Drug designation in Japan for the treatment of patients with #Duchenne muscular dystrophy (#DMD) who have mutations in the DMD gene that are amenable to exon [--] skipping. Read here: https://bit.ly/4gM1tG0 https://bit.ly/4gM1tG0"
X Link 2025-09-29T12:47Z [----] followers, [---] engagements

"Next week well be at #WMS2025 to highlight data demonstrating the potential of our therapies to address the underlying causes of neuromuscular diseases to provide functional improvement. See the program and visit us at our booth: https://bit.ly/3WlJwVr https://bit.ly/3WlJwVr"
X Link 2025-10-03T18:48Z [----] followers, [---] engagements

"Join us at the @RNASymposium where well give a presentation on how the FORCE platform was designed to deliver targeted therapeutics to provide functional improvement for people with neuromuscular diseases. Register: https://bit.ly/3J7ihv3 https://bit.ly/3J7ihv3"
X Link 2025-10-27T17:50Z [----] followers, [---] engagements

"We're taking our story on the road this month to investor conferences. Join us to learn more about our late-stage neuromuscular disease pipeline by registering for our fireside chats: $DYN https://bit.ly/4oK7rKs https://bit.ly/4oK7rKs"
X Link 2025-11-03T14:10Z [----] followers, [---] engagements

"Today we announced our third quarter [----] financial results highlighting progress for our #DMD and #DM1 programs and anticipated milestones. Read here: $DYN https://bit.ly/3LqkaDI https://bit.ly/3LqkaDI"
X Link 2025-11-05T21:32Z [----] followers, [---] engagements

"Drugs get lost in the margins. This insight from our recent FORCEs in Biotech conversation with Christoph Lengauer CSO at @Curie_Bio says it all: success isnt just about a breakthrough idea. Its about seeing the full arc from science to approval and commercialization"
X Link 2025-12-03T18:26Z [----] followers, [---] engagements

"At an upcoming @Nature conference Dyne will share how our FORCE platform is tackling one of biotechs biggest challenges: delivering therapies that drive functional improvement in people with neuromuscular diseases. See the agenda: https://bit.ly/4iE0GZ0 https://bit.ly/4iE0GZ0"
X Link 2025-12-05T15:48Z [----] followers, [---] engagements

"A historic step forward for the Duchenne community. DMD has been added to the RUSP enabling earlier diagnosis & access to care when it matters most. TY to @ParentProjectMD @MDAorg @HHSGov @HRSAgov & families whose advocacy made this possible. https://bit.ly/44r94oQ https://bit.ly/44r94oQ"
X Link 2025-12-16T21:55Z [----] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing